The Wolverine Stack
BPC-157 + TB-500 combined healing protocol guide
The “Wolverine Stack” is the community name for the combination of BPC-157 and TB-500, the two most popular healing peptides stacked together. The name stuck because users describe the recovery speed as superhuman: injuries that normally take months resolving in weeks. The stack works because BPC-157 and TB-500 target entirely different healing pathways, creating a synergistic effect that neither peptide achieves alone.
Why BPC-157 + TB-500?
Stacking BPC-157 with TB-500 is not just taking two healing peptides at once. Their mechanisms are complementary rather than redundant, which is what makes the combination compelling.
BPC-157: Local Repair
Body Protection Compound-157
- Upregulates VEGF (vascular endothelial growth factor) to build new blood vessels at the injury site
- Modulates nitric oxide pathways to improve blood flow and reduce inflammation locally
- Stimulates growth factor expression (EGF, FGF) for direct tissue regeneration
- Most effective when injected near the injury. Local concentration matters
TB-500: Systemic Healing
Thymosin Beta-4 fragment
- Regulates actin, a cell-building protein essential for cell migration and wound repair
- Reduces systemic inflammation through broad anti-inflammatory signaling
- Promotes cell migration, so stem cells and repair cells move to the damage site faster
- Works systemically regardless of injection site. Subcutaneous anywhere is effective
The synergy
BPC-157 builds new blood supply and upregulates growth factors at the injury site while TB-500 reduces whole-body inflammation and drives repair cells toward that same site. One is the construction crew, the other clears the road and sends reinforcements. Together, they address both the local tissue damage and the systemic inflammatory environment that slows healing.
Dosing Protocol
The standard Wolverine Stack protocol uses each peptide at its established individual dose. There is no need to reduce either dose when stacking. They do not compete for the same receptors or pathways.
Standard Wolverine Stack Protocol
Inject subcutaneous near injury site, once daily
Inject subcutaneous anywhere, twice weekly
Followed by 2-4 weeks off
Combined cost for both peptides
Reconstitution
Both peptides arrive as lyophilized (freeze-dried) powder and need to be reconstituted with bacteriostatic water before use. The process is identical for each. Only the math changes.
BPC-157
Standard vials come as 5 mg. Reconstitute with 2 mL of bacteriostatic water for a concentration of 2.5 mg/mL (2,500 mcg/mL). A 500 mcg dose is 0.2 mL (20 units on an insulin syringe).
TB-500
Standard vials come as 5 mg or 10 mg. Reconstitute a 5 mg vial with 2 mL of bacteriostatic water for a concentration of 2.5 mg/mL. A 2.5 mg dose is 1 mL (100 units on an insulin syringe).
Use our reconstitution calculator to get exact syringe units for your specific vial size and desired dose, or read our full reconstitution guide if this is your first time working with lyophilized peptides.
Injection Site Strategy
Where you inject matters for BPC-157 but not for TB-500. This is one of the key practical differences when running the stack.
BPC-157: Inject near the injury
BPC-157's local repair mechanisms (angiogenesis, growth factor upregulation) are enhanced by proximity to the injury site. Inject subcutaneously as close to the affected area as practical. For a knee injury, inject in the fat pad around the knee. For a shoulder issue, inject in the deltoid area. For gut healing, oral administration or abdominal subcutaneous injection is preferred.
TB-500: Inject anywhere
TB-500 works systemically through cell migration and anti-inflammatory signaling. Injection site does not affect efficacy. Most users inject subcutaneously in the abdomen or thigh for convenience. Rotate injection sites to avoid irritation.
Practical approach
Many users inject BPC-157 near the injury site and TB-500 in the abdomen during the same session. On TB-500 injection days (2x/week), you do both injections. On the other days, you only inject BPC-157 near the injury. Some users combine both into a single syringe and inject near the injury. This is also acceptable.
Cycle Structure
Standard cycle
Cycle both peptides on and off together. There is no benefit to staggering start or stop dates. Some users run a shorter 4-week cycle for minor injuries or a full 6-week cycle for more significant damage. Discuss cycle length with your healthcare provider based on your specific situation.
What to Expect Week by Week
Individual responses vary, but this timeline reflects commonly reported experiences from community members running the Wolverine Stack. Results depend on injury severity, individual biology, and dosing.
Settling in
Most users feel no dramatic changes yet. Some report reduced inflammation and mild pain relief, likely from BPC-157's early effects. Injection site soreness is normal and usually resolves within days.
Early improvement
Noticeable reduction in pain and swelling for many users. Range of motion may begin to improve. This is typically when BPC-157's angiogenesis effects start becoming apparent and TB-500's anti-inflammatory signaling reaches steady state.
Measurable progress
Most users report clear improvement by this point. Tendon and ligament injuries often show meaningful functional recovery. Chronic joint pain may decrease significantly. This is where the synergistic effect of the stack becomes most apparent.
Consolidation
Continued healing and strengthening. Users with more severe injuries often see the most gains during this period as tissue remodeling progresses. Some users begin tapering dose toward the end of week 5-6 rather than stopping abruptly, though both approaches are common.
Assessment
Healing gains typically persist after discontinuation. The new blood vessels and repaired tissue remain. Assess your progress during the off period. If additional healing is needed, a second cycle can be started after 2-4 weeks off.
Common Use Cases
The Wolverine Stack is used across a wide range of healing scenarios. These are the most commonly reported applications in the community.
Tendon & ligament injuries
The most popular use case. Rotator cuff strains, Achilles tendinopathy, tennis elbow, patellar tendinitis, and similar connective tissue injuries.
Post-surgery recovery
Users report accelerated recovery from orthopedic surgeries including ACL reconstruction, meniscus repair, and shoulder surgeries. Always discuss with your surgeon.
Chronic joint pain
Long-standing knee, hip, and shoulder pain from overuse or mild degeneration. The anti-inflammatory and tissue repair combination addresses both symptoms and underlying damage.
Gut healing
BPC-157's gastric origin makes it particularly effective for gut issues. TB-500's systemic anti-inflammatory effects complement this. Oral BPC-157 plus injectable TB-500 is a common approach.
Muscle strains
Moderate to severe muscle pulls and tears. TB-500's actin regulation is particularly relevant here, while BPC-157 builds new blood supply to the damaged muscle tissue.
General recovery
Athletes and active individuals use the stack during heavy training blocks or between competitive seasons to address accumulated minor injuries and inflammation.
Stacking with Other Compounds
Some users add a third compound to the Wolverine Stack for specific goals. The most common addition is GHK-Cu.
GHK-Cu (Copper peptide)
GHK-Cu is a naturally occurring copper peptide that supports tissue remodeling, collagen synthesis, and anti-inflammatory signaling. Some users add GHK-Cu at 1-2 mg/day to the Wolverine Stack for enhanced skin healing, scar reduction, and additional anti-inflammatory support. It is available in both injectable and topical forms. Adding GHK-Cu increases protocol complexity and cost. Most users find the base BPC-157 + TB-500 stack sufficient.
Keep compound stacking as simple as possible. The Wolverine Stack is effective on its own for the vast majority of healing scenarios. Adding more compounds increases cost, injection burden, and the difficulty of attributing results. Discuss any multi-compound protocol with your healthcare provider.
Sourcing Quality Peptides
The Wolverine Stack is only as good as the peptides you use. Gray market failure rates for peptides run 30-75%, meaning underdosed, contaminated, or completely inactive product. Third-party testing, valid Certificates of Analysis, and vendor reputation matter significantly.
Read our complete guide to finding reliable peptide sources before purchasing. At minimum, verify HPLC purity above 98%, endotoxin levels below 0.5 EU/mg, and that batch numbers on COAs match your vials.
FAQ
Yes. Many users draw both reconstituted peptides into a single insulin syringe and inject them together. The peptides do not interact negatively or degrade each other in solution. Just be mindful of your total injection volume, keeping it under 1 mL per injection site is standard practice.
Most users report noticeable improvement within 1-2 weeks for acute injuries. BPC-157 tends to show effects first due to daily dosing and shorter half-life. The full synergistic benefit of the stack typically becomes apparent by weeks 2-3. Chronic or severe injuries may take the full 4-6 week cycle before significant improvement.
Cycling is standard practice. Most protocols call for 4-6 weeks on followed by 2-4 weeks off. While there is no established evidence of receptor desensitization for either peptide, cycling allows your body to consolidate healing gains and helps you assess how much improvement persists without active dosing. Discuss cycle length with your provider.
BPC-157 has meaningful oral bioavailability and is sometimes used orally for gut-related healing within the stack. However, for musculoskeletal injuries, subcutaneous injection near the injury site is preferred because it delivers higher local concentrations. Some users take oral BPC-157 for gut support alongside injectable BPC-157 near the injury, though this increases total dosing and should be discussed with a provider.
Neither BPC-157 nor TB-500 has completed FDA-approved human clinical trials, so long-term safety data is limited. Animal studies show favorable safety profiles at therapeutic doses with no reported organ toxicity. Anecdotally, users report the stack is well-tolerated during standard 4-6 week cycles. Running the stack continuously without breaks is not recommended. Always discuss long-term protocols with your healthcare provider.
There are no known direct interactions between BPC-157/TB-500 and GLP-1 receptor agonists like semaglutide or tirzepatide. Some users run healing peptides alongside GLP-1 protocols without reported issues. However, combining multiple compounds increases complexity. Discuss any multi-compound protocols with your prescribing provider before starting.
Ready to start your protocol?
Read the full protocol for each peptide, compare the two side-by-side, or use our calculator for exact reconstitution math.